Updated Jul 16, 2026
Cook Meredith has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $534K.

Meredith Cook serves as the Senior Vice President, General Counsel, and Secretary at ANI Pharmaceuticals Inc. She has been involved in various SEC filings and plays a key role in the legal and compliance aspects of the company.
| Role | SR. VP, GENERAL COUNSEL & SEC. |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-14 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale [10b5-1] | 500 | $81.84 | $41K |
| 2026-06-15 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale | 500 | $82.03 | $41K |
| 2026-05-13 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale | 500 | $78.16 | $39K |
| 2026-04-13 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale [10b5-1] | 500 | $77.95 | $39K |
| 2026-03-13 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale [10b5-1] | 500 | $72.62 | $36K |
| 2026-03-02 | ANIP | ANI PHARMACEUTICALS INC | F — Tax withholding / forfeiture | 1.6K | $73.90 | $115K |
| 2026-03-02 | ANIP | ANI PHARMACEUTICALS INC | A — Grant or award | 13.9K | $77.15 | $1.07M |
| 2026-02-17 | ANIP | ANI PHARMACEUTICALS INC | F — Tax withholding / forfeiture [10b5-1] | 1.8K | $77.36 | $138K |
| 2026-02-17 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale [10b5-1] | 500 | $76.80 | $38K |
| 2026-02-17 | ANIP | ANI PHARMACEUTICALS INC | F — Tax withholding / forfeiture [10b5-1] | 1.5K | $76.70 | $118K |
| 2026-02-13 | ANIP | ANI PHARMACEUTICALS INC | F — Tax withholding / forfeiture | 3.0K | $76.25 | $230K |
| 2026-01-14 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale [10b5-1] | 500 | $84.33 | $42K |
| 2025-10-13 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale | 400 | $90.09 | $36K |
| 2025-09-12 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale | 400 | $98.42 | $39K |
| 2025-08-13 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale | 400 | $88.87 | $36K |
| 2025-07-18 | ANIP | ANI PHARMACEUTICALS INC | F — Tax withholding / forfeiture | 2.1K | $66.30 | $137K |
| 2025-07-14 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale | 400 | $64.88 | $26K |
| 2025-06-13 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale | 400 | $61.37 | $25K |
| 2025-05-13 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale | 400 | $62.20 | $25K |
| 2025-04-14 | ANIP | ANI PHARMACEUTICALS INC | S — Open-market sale | 400 | $68.96 | $28K |
Meredith Cook serves as the Senior Vice President, General Counsel, and Secretary at ANI Pharmaceuticals Inc. She has been involved in various SEC filings and plays a key role in the legal and compliance aspects of the company.…
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 17 open-market sales ($534K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Cook Meredith profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.